Candel Therapeutics, Inc. (CADL)
7.80
+0.17
(+2.23%)
USD |
NASDAQ |
May 07, 16:00
7.88
+0.08
(+1.03%)
After-Hours: 20:00
Candel Therapeutics SG&A Expense (TTM) : 17.77M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Oncolytics Biotech, Inc. | 10.90M |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Alnylam Pharmaceuticals, Inc. | 1.293B |
| Savara, Inc. | 42.06M |
| BioMarin Pharmaceutical, Inc. | 946.91M |